Related Experiment Video
Updated: Oct 26, 2025
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.5K
Retinoblastoma from human stem cell-derived retinal organoids
Jackie L Norrie1, Anjana Nityanandam1, Karen Lai1
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Nature Communications
|July 28, 2021
Summary
Researchers created a new laboratory model for retinoblastoma, a childhood eye cancer. This model uses patient-derived stem cells to accurately replicate human retinoblastoma formation and study its origins.
Area of Science:
- Ophthalmology
- Oncology
- Stem Cell Biology
Background:
- Retinoblastoma is a childhood retinal cancer caused by RB1 gene inactivation.
- Germline RB1 mutations increase retinoblastoma and other cancer risks.
- Existing mouse models partially mimic human retinoblastoma but have cellular differentiation differences.
Purpose of the Study:
- To develop a more accurate laboratory model of human retinoblastoma formation.
- To investigate the cellular origins and tumorigenesis mechanisms of retinoblastoma.
Main Methods:
- Generated induced pluripotent stem cells (iPSCs) from 15 participants with germline RB1 mutations.
- Differentiated iPSCs into retinal organoids using a 3D culture system.
- Inoculated immunocompromised mice with retinal organoids to induce tumor formation.
Main Results:
- Retinal organoids derived from patient iPSCs successfully formed retinoblastomas in mice.
- The induced retinoblastomas exhibited molecular, cellular, and genomic features identical to human retinoblastomas.
- This iPSC-based model accurately recapitulates human retinoblastoma.
Conclusions:
- Patient-derived iPSC-based retinal organoids provide a robust model for studying human retinoblastoma.
- This model offers valuable insights into the cellular origins and tumorigenesis of this childhood cancer.
- The model aids in understanding the consequences of RB1 gene inactivation in retinoblastoma development.
